ChemPartner PharmaTech Co Ltd Cash Flow Reinvestment Rate
ChemPartner PharmaTech Co Ltd cash flow reinvestment rate. ChemPartner PharmaTech Co Ltd (300149) has a Cash Flow Reinvestment Rate of 2.91x as of June 2023, reinvesting CN¥82.22 Million (capex CN¥66.62 Million plus investments CN¥-15.60 Million) from operating cash flow of CN¥28.21 Million. See ChemPartner PharmaTech Co Ltd (300149) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ChemPartner PharmaTech Co Ltd (2007–2025)
Cash flow reinvestment rate of ChemPartner PharmaTech Co Ltd from 2007 to 2025. Historical reinvestment intensity for ChemPartner PharmaTech Co Ltd across 19 annual periods. Explore debt repayment capacity of ChemPartner PharmaTech Co Ltd to assess how comfortably operating cash covers total debt obligations.
ChemPartner PharmaTech Co Ltd Cash Flow Reinvestment Rate by Year (2007–2025)
ChemPartner PharmaTech Co Ltd cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for ChemPartner PharmaTech Co Ltd. For the full cash flow conversion analysis, see 300149 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.53x | CN¥101.07 Million | CN¥190.50 Million | CN¥62.47 Million | ▲ +28.5% |
| 2024 | 0.41x | CN¥69.47 Million | CN¥168.21 Million | CN¥69.25 Million | ▼ -71.9% |
| 2023 | 1.47x | CN¥221.69 Million | CN¥150.99 Million | CN¥201.29 Million | ▼ -22.9% |
| 2022 | 1.90x | CN¥499.85 Million | CN¥262.46 Million | CN¥336.20 Million | ▲ +137.9% |
| 2021 | 0.80x | CN¥302.77 Million | CN¥378.22 Million | CN¥286.00 Million | ▼ -33.3% |
| 2020 | 1.20x | CN¥412.05 Million | CN¥343.16 Million | CN¥394.03 Million | ▲ +0.3% |
| 2019 | 1.20x | CN¥257.54 Million | CN¥215.07 Million | CN¥254.23 Million | ▲ +103.7% |
| 2018 | 0.59x | CN¥142.94 Million | CN¥243.19 Million | CN¥109.88 Million | ▼ -51.5% |
| 2017 | 1.21x | CN¥76.93 Million | CN¥63.43 Million | CN¥4.21 Million | ▲ +260.8% |
| 2016 | 0.34x | CN¥23.95 Million | CN¥71.26 Million | CN¥10.45 Million | ▲ +33.6% |
| 2015 | 0.25x | CN¥25.33 Million | CN¥100.69 Million | CN¥25.33 Million | ▼ -80.5% |
| 2014 | 1.29x | CN¥76.93 Million | CN¥59.63 Million | CN¥76.93 Million | ▼ -5.4% |
| 2013 | 1.36x | CN¥63.17 Million | CN¥46.32 Million | CN¥63.17 Million | ▼ -39.9% |
| 2012 | 2.27x | CN¥124.91 Million | CN¥55.09 Million | CN¥124.91 Million | ▲ +25.6% |
| 2011 | 1.81x | CN¥21.06 Million | CN¥11.66 Million | CN¥21.06 Million | ▲ +122.6% |
| 2010 | 0.81x | CN¥16.89 Million | CN¥20.81 Million | CN¥16.89 Million | ▼ -42.8% |
| 2009 | 1.42x | CN¥18.83 Million | CN¥13.28 Million | CN¥18.83 Million | ▲ +26.4% |
| 2008 | 1.12x | CN¥24.33 Million | CN¥21.70 Million | CN¥24.33 Million | ▲ +285.7% |
| 2007 | 0.29x | CN¥6.45 Million | CN¥22.19 Million | CN¥6.45 Million | — |